Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae

Cardiovascular Research

Volumn 70, Issue 1, 2006, Pages 31-41

  Mineo, Chieko ^a   Shaul, Philip W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

C reactive protein; Caveolae; Endothelium; Estrogen; High density lipoprotein; Nitric oxide

Indexed keywords

APOLIPOPROTEIN A1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FC RECEPTOR; HIGH DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SCAVENGER RECEPTOR BI; SPHINGOSINE 1 PHOSPHATE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAVEOLA; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CELL STRAIN COS7; ENDOTHELIUM CELL; ENZYME ACTIVATION; ESTROGEN BINDING; EXPERIMENTAL MODEL; HUMAN; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAVEOLAE; ENDOTHELIAL CELLS; ESTROGENS; HUMANS; LIPOPROTEINS, HDL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RISK; SIGNAL TRANSDUCTION;

EID: 32444440329     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.01.025     Document Type: Review

References (71)

1. D.G. Harrison Endothelial dysfunction in atherosclerosis Basic Res Cardiol 89 Suppl 1 1994 87 102
2. N.A. Flavahan Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity Circulation 85 1992 1927 1938
3. J.R. Vane, E.E. Anggard, and R.M. Botting Regulatory functions of the vascular endothelium N Engl J Med 323 1990 27 36
4. J.R. Vane, and R.M. Botting Formation by the endothelium of prostacyclin, nitric oxide and endothelin J Lipid Mediat 6 1993 395 404
5. S. Moncada, and A. Higgs The l-arginine-nitric oxide pathway N Engl J Med 329 1993 2002 2012
6. C. Nathan, and Q.W. Xie Regulation of biosynthesis of nitric oxide J Biol Chem 269 1994 13725 13728
7. R.A. Cohen The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease Prog Cardiovasc Dis 38 1995 105 128
8. D.S. Bredt, and S.H. Snyder Nitric oxide: a physiologic messenger molecule Annu Rev Biochem 63 1994 175 195
9. P.W. Shaul Regulation of eNOS: location, location, location Annu Rev Physiol 64 2002 749 774
10. P.W. Shaul, E.J. Smart, L.J. Robinson, Z. German, I.S. Yuhanna, and Y. Ying Acylation targets eNOS to plasmalemmal caveolae J Biol Chem 271 1996 6518 6522
11. G. Garcia-Cardena, P. Oh, J. Liu, J.E. Schnitzer, and W.C. Sessa Targeting of NOS to endothelial cell caveolae via palmitoylation: implications for NO signaling Proc Natl Acad Sci U S A 93 1996 6448 6453
12. A. Blair, P.W. Shaul, I.S. Yuhanna, P.A. Conrad, and E.J. Smart Oxidized LDL displaces eNOS from plasmalemmal caveolae and impairs eNOS activation J Biol Chem 274 1999 32512 32519
13. A. Uittenbogaard, P.W. Shaul, I.S. Yuhanna, A. Blair, and E.J. Smart HDL prevents oxidized LDL-induced inhibition of eNOS localization and activation in caveolae J Biol Chem 275 2000 11278 11283
14. J.F. Kincer, A. Uittenbogaard, J. Dressman, T.M. Guerin, M. Febbraio, and L. Guo Hypercholesterolemia promotes a CD36-dependent and eNOS-mediated vascular dysfunction J Biol Chem 277 2002 23525 23533
15. I.S. Yuhanna, Y. Zhu, B.E. Cox, L.D. Hahner, S. Osborne-Lawrence, and P. Lu HDL binding to scavenger receptor-BI activates endothelial nitric oxide synthase Nat Med 7 2001 853 857
16. R.J. Bisoendial, G.K. Hovingh, J.H. Levels, P.G. Lerch, I. Andresen, and M.R. Hayden Restoration of endothelial function by increasing HDL in subjects with isolated low HDL Circulation 107 2003 2944 2948
17. J.T. Kuvin, M.E. Ramet, A.R. Patel, N.G. Pandian, M.E. Mendelsohn, and R.H. Karas A novel mechanism for the beneficial vascular effects of HDL cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression Am Heart J 144 2002 165 172
18. J.T. Kuvin, A.R. Patel, M. Sidhu, W.M. Rand, K.A. Sliney, and N.G. Pandian Relation between HDL cholesterol and peripheral vasomotor function Am J Cardiol 92 2003 275 279
19. X.P. Li, S.P. Zhao, X.Y. Zhang, L. Liu, M. Gao, and Q.C. Zhou Protective effect of HDL on endothelium-dependent vasodilatation Int J Cardiol 73 2000 231 236
20. L.E. Spieker, I. Sudano, D. Hurlimann, P.G. Lerch, M.G. Lang, and C. Binggeli HDL restores endothelial function in hypercholesterolemic men Circulation 105 2002 1399 1402
21. A.M. Zeiher, V. Schachlinger, S.H. Hohnloser, B. Saurbier, and H. Just Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated HDL levels ameliorate abnormal vasoconstriction in early atherosclerosis Circulation 89 1994 2525 2532
22. D.J. Rader Regulation of reverse cholesterol transport and clinical implications Am J Cardiol 92 2003 42J 49J
23. B.G. Drew, N.H. Fidge, G. Gallon-Beaumier, B.E. Kemp, and B.A. Kingwell HDL and apolipoprotein AI increase eNOS activity by protein association and multisite phosphorylation Proc Natl Acad Sci U S A 101 2004 6999 7004
24. C. Mineo, I.S. Yuhanna, M.J. Quon, and P.W. Shaul HDL-induced eNOS activation is mediated by Akt and MAP kinases J Biol Chem 278 2003 9142 9149
25. J.R. Nofer, G.M. van der, M. Tolle, I. Wolinska, L.K. von Wnuck, and H.A. Baba HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3 J Clin Invest 113 2004 569 581
26. B. Levkau, S. Hermann, G. Theilmeier, G.M. van der, J. Chun, and O. Schober High-density lipoprotein stimulates myocardial perfusion in vivo Circulation 110 2004 3355 3359
27. M. Gong, M. Wilson, T. Kelly, W. Su, J. Dressman, and J. Kincer HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner J Clin Invest 111 2003 1579 1587
28. S. Seetharam, C. Mineo, A.K. Gormley, L.L. Gibson, W. Vongpatanasin, and K. Chambliss HDL promotes endothelial cell migration and reendothelialization via scavenger receptor-B Type I Circ Res 98 2006 63 72
29. S. Miura, M. Fujino, Y. Matsuo, A. Kawamura, H. Tanigawa, and H. Nishikawa HDL-induced angiogenesis requires the activation of Ras/MAP kinase in human coronary artery endothelial cells Arterioscler Thromb Vasc Biol 23 2003 802 808
30. M.A. Connelly, M. De La Llera-Moya, Y. Peng, D. Drazul-Schrader, G.H. Rothblat, and D.L. Williams Separation of lipid transport functions by mutations in the extracellular domain of scavenger receptor class B, type I J Biol Chem 278 2003 25773 25782
31. C. Assanasen, C. Mineo, D. Seetharam, I.S. Yuhanna, Y.L. Marcel, and M.A. Connelly Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling J Clin Invest 115 2005 969 977
32. A.J. Brown, L. Sun, J.D. Feramisco, M.S. Brown, and J.L. Goldstein Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism Mol Cell 10 2002 237 245
33. M.E. Mendelsohn Mechanisms of estrogen action in the cardiovascular system J Steroid Biochem Mol Biol 74 2000 337 343
34. R.A. Khalil Sex hormones as potential modulators of vascular function in hypertension Hypertension 46 2005 249 254
35. M.E. Mendelsohn, and R.H. Karas Molecular and cellular basis of cardiovascular gender differences Science 308 2005 1583 1587
36. K.L. Chambliss, and P.W. Shaul Estrogen modulation of eNOS Endocr Rev 23 2002 665 666
37. R.L. Lantin-Hermoso, C.R. Rosenfeld, I.S. Yuhanna, Z. German, Z. Chen, and P.W. Shaul Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium Am J Physiol 273 1997 L119 L126
38. T. Caulin-Glaser, G. Garcia-Cardena, P. Sarrel, W.C. Sessa, and J.R. Bender 17 Beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization Circ Res 81 1997 885 892
39. Z. Chen, I.S. Yuhanna, Z. Galcheva-Gargova, R.H. Karas, M.E. Mendelsohn, and P.W. Shaul Estrogen receptor alpha mediates the nongenomic activation of eNOS by estrogen J Clin Invest 103 1999 401 406
40. M.P. Haynes, D. Sinha, K.S. Russell, M. Collinge, D. Fulton, and M. Morales-Ruiz Membrane estrogen receptor engagement activates eNOS via the PI3-kinase-Akt pathway in human endothelial cells Circ Res 87 2000 677 682
41. T. Simoncini, A. Hafezi-Moghadam, D.P. Brazil, K. Ley, W.W. Chin, and J.K. Liao Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase Nature 407 2000 538 541
42. K. Hisamoto, M. Ohmichi, H. Kurachi, J. Hayakawa, Y. Kanda, and Y. Nishio Estrogen induces the Akt-dependent activation of eNOS in vascular endothelial cells J Biol Chem 276 2001 3459 3467
43. R.M. Goetz, H.S. Thatte, P. Prabhakar, M.R. Cho, T. Michel, and D.E. Golan Estradiol induces the calcium-dependent translocation of eNOS Proc Natl Acad Sci U S A 96 1999 2788 2793
44. G.B. Stefano, V. Prevot, J.C. Beauvillain, P. Cadet, C. Fimiani, and I. Welters Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia Circulation 101 2000 1594 1597
45. K.S. Russell, M.P. Haynes, T. Caulin-Glaser, J. Rosneck, W.C. Sessa, and J.R. Bender Estrogen stimulates heat shock protein 90 binding to eNOS in human vascular endothelial cells. Effects on calcium sensitivity and NO release J Biol Chem 275 2000 5026 5030
46. K.L. Chambliss, I.S. Yuhanna, C. Mineo, P. Liu, Z. German, and T.S. Sherman Estrogen receptor alpha and eNOS are organized into a functional signaling module in caveolae Circ Res 87 2000 E44 E52
47. L. Li, M.P. Haynes, and J.R. Bender Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells Proc Natl Acad Sci U S A 100 2003 4807 4812
48. F. Acconcia, P. Ascenzi, G. Fabozzi, P. Visca, and M. Marino S-Palmitoylation modulates human estrogen receptor-alpha functions Biochem Biophys Res Commun 316 2004 878 883
49. M. Razandi, G. Alton, A. Pedram, S. Ghonshani, P. Webb, and E.R. Levin Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane Mol Cell Biol 23 2003 1633 1646
50. K.L. Chambliss, I.S. Yuhanna, R.G. Anderson, M.E. Mendelsohn, and P.W. Shaul ERbeta has nongenomic action in caveolae Mol Endocrinol 16 2002 938 946
51. M.H. Wyckoff, K.L. Chambliss, C. Mineo, I.S. Yuhanna, M.E. Mendelsohn, and S.M. Mumby Plasma membrane estrogen receptors are coupled to eNOS through Galpha(i) J Biol Chem 276 2001 27071 27076
52. Q. Lu, D.C. Pallas, H.K. Surks, W.E. Baur, M.E. Mendelsohn, and R.H. Karas Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha Proc Natl Acad Sci U S A 101 2004 17126 17131
53. K.L. Chambliss, L. Simon, I.S. Yuhanna, C. Mineo, and P.W. Shaul Dissecting the basis of nongenomic activation of eNOS by estradiol: role of ERalpha domains with known nuclear functions Mol Endocrinol 19 2005 277 289
54. S. Fichtlscherer, G. Rosenberger, D.H. Walter, S. Breuer, S. Dimmeler, and A.M. Zeiher Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease Circulation 102 2000 1000 1006
55. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
56. S. Verma, and E.T. Yeh C-reactive protein and atherothrombosis-beyond a biomarker: an actual partaker of lesion formation Am J Physiol 285 2003 R1253 R1256
57. M.B. Pepys, and G.M. Hirschfield C-reactive protein: a critical update J Clin Invest 111 2003 1805 1812
58. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, and A. Rumley C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
59. I. Jialal, S. Devaraj, and S.K. Venugopal C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44 2004 6 11
60. S. Black, I. Kushner, and D. Samols C-reactive protein J Biol Chem 279 2004 48487 48490
61. T.W. Du Clos The interaction of C-reactive protein and serum amyloid P component with nuclear antigens Mol Biol Rep 23 1996 253 260
62. C. Mineo, A.K. Gormley, I.S. Yuhanna, S. Osborne-Lawrence, L.L. Gibson, and L. Hahner Fc gamma RIIB mediates C-reactive protein inhibition of eNOS Circ Res 97 2005 1124 1131
63. B.J. Michell, Z. Chen, T. Tiganis, D. Stapleton, F. Katsis, and D.A. Power Coordinated control of eNOS phosphorylation by protein kinase C and the cAMP-dependent protein kinase J Biol Chem 276 2001 17625 17628
64. D.M. Greif, R. Kou, and T. Michel Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites Biochemistry 41 2002 15845 15853
65. D. Bharadwaj, M.P. Stein, M. Volzer, C. Mold, and T.W. Du Clos The major receptor for C-reactive protein on leukocytes is fcgamma receptor II J Exp Med 190 1999 585 590
66. R.E. Crowell, T.W. Du Clos, G. Montoya, E. Heaphy, and C. Mold C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fc gamma RI J Immunol 147 1991 3445 3451
67. L.L. Marnell, C. Mold, M.A. Volzer, R.W. Burlingame, and T.W. Du Clos C-reactive protein binds to Fc gamma RI in transfected COS cells J Immunol 155 1995 2185 2193
68. M.P. Stein, J.C. Edberg, R.P. Kimberly, E.K. Mangan, D. Bharadwaj, and C. Mold C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific J Clin Invest 105 2000 369 376
69. M.P. Stein, C. Mold, and T.W. Du Clos C-reactive protein binding to murine leukocytes requires Fc gamma receptors J Immunol 164 2000 1514 1520
70. M.J. Aman, A.C. Tosello-Trampont, and K. Ravichandran Fc gamma RIIB1/SHIP-mediated inhibitory signaling in B cells involves lipid rafts J Biol Chem 276 2001 46371 46378
71. J.V. Ravetch, and S. Bolland IgG Fc receptors Annu Rev Immunol 19 2001 275 290